Literature DB >> 12771406

Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir.

Wendy Harris1, Peter Collins1, Rob J Fenton1, Wendy Snowden1, Mike Sowa1, Graham Darby1.   

Abstract

A panel of 10 clinical isolates of herpes simplex virus (HSV) deficient in the expression of thymidine kinase (TK) and phenotypically resistant to aciclovir was characterized. Sequence analysis revealed a variety of mutations in TK (nucleotide substitutions, insertions and deletions), most of which resulted in truncated TK polypeptides. In line with previous reports, the most common mutation was a single G insertion in the 'G-string' motif. One HSV-1 isolate and two HSV-2 isolates appeared to encode full-length polypeptides and, in each case, an amino acid substitution likely to be responsible for the phenotype was identified. Pathogenicity was determined using a zosteriform model of HSV infection in BALB/c mice. The majority of isolates appeared to show impaired growth at the inoculation site compared with wild-type virus. They also showed poor replication in the peripheral nervous system and little evidence of zosteriform spread. One exception was isolate 4, which had a double G insertion in the G-string but, nevertheless, exhibited zosteriform spread. These studies confirmed that TK-deficient viruses display a range of neurovirulence with respect to latency and zosteriform spread. These results are discussed in the light of previous experience with TK-deficient viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771406     DOI: 10.1099/vir.0.18880-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.

Authors:  Anthony Griffiths
Journal:  Drug Resist Updat       Date:  2011-09-22       Impact factor: 18.500

Review 2.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin.

Authors:  Graciela Andrei; Jan Balzarini; Pierre Fiten; Erik De Clercq; Ghislain Opdenakker; Robert Snoeck
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.

Authors:  Anthony Griffiths; Malen A Link; Caroline L Furness; Donald M Coen
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Authors:  Kening Wang; Gowtham Mahalingam; Susan E Hoover; Erik K Mont; Steven M Holland; Jeffrey I Cohen; Stephen E Straus
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.

Authors:  Natacha Coen; Sophie Duraffour; Kazuhiro Haraguchi; Jan Balzarini; Joost J van den Oord; Robert Snoeck; Graciela Andrei
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

7.  Effective Prophylactic Therapy for Exposure to Monkey B Virus (Macacine alphaherpesvirus 1).

Authors:  Lara K Maxwell; Darla H Black; George E Wright; Melanie A Breshears; Richard Eberle
Journal:  Comp Med       Date:  2019-12-06       Impact factor: 1.565

8.  Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.

Authors:  Natsumi Omura; Hikaru Fujii; Tomoki Yoshikawa; Souichi Yamada; Shizuko Harada; Takuya Inagaki; Miho Shibamura; Haruko Takeyama; Masayuki Saijo
Journal:  Virol J       Date:  2017-03-21       Impact factor: 4.099

9.  Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.

Authors:  Maimoona S Bhutta; Oren Shechter; Elisa S Gallo; Stephen D Martin; Esther Jones; Gustavo F Doncel; Ronen Borenstein
Journal:  Viruses       Date:  2021-01-09       Impact factor: 5.048

Review 10.  Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.

Authors:  Paula A Suazo; Eduardo I Tognarelli; Alexis M Kalergis; Pablo A González
Journal:  Med Microbiol Immunol       Date:  2014-09-11       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.